Coating zwitterionic amino acid L-DOPA to increase fouling resistance of forward osmosis membrane

被引:78
|
作者
Anh Nguyen [1 ]
Azari, Sara [1 ]
Zou, Linda [1 ]
机构
[1] Univ S Australia, SA Water Ctr Water Management & Reuse, Adelaide, SA 5095, Australia
关键词
Forward osmosis; Membrane fouling resistance; L-DOPA; Hydrophilicity; Surface modification; AMMONIA-CARBON DIOXIDE; POWER-GENERATION; DESALINATION; ENERGY; TEMPERATURE; DRAW;
D O I
10.1016/j.desal.2012.11.038
中图分类号
TQ [化学工业];
学科分类号
0817 ;
摘要
In this study, the HTI Forward Osmosis (FO) membrane surfaces were modified by the deposition of poly amino acid 3-(3,4-Dihydroxyphenyl)-L-alanine (L-DOPA), a zwitterionic polymer on the membrane surface in order to enhance the fouling resistance of the FO membranes. The modification took place on the porous layer/side of the membranes. The modified membrane surfaces became more hydrophilic with a reduced initial water contact angle. Accelerated fouling experiments were conducted in pressure retarded osmosis (PRO) mode, in which the porous layer of membrane faced the feed solution. The feed solution comprised alginic acid sodium salt (MS) and calcium ions (CaCl2). The filtration results proved an effective improvement of fouling resistance of the L-DOPA coated membranes. The membrane samples with a 12-hour coating achieved 30% less fouling compared to the uncoated sample. The L-DOPA coating method is simple and direct; it has the potential for scaled up industrial applications. (C) 2012 Elsevier B.V. All rights reserved.
引用
收藏
页码:82 / 87
页数:6
相关论文
共 50 条
  • [41] Simultaneous synthesis of L-DOPA and oxidation of D-amino acid by specific coupling of a peroxidase to D-amino acid oxidase
    Chen, Yao
    Chu, Hao
    Liu, Wei
    Feng, Wei
    ENZYME AND MICROBIAL TECHNOLOGY, 2019, 121 : 8 - 16
  • [42] EFFECT OF L-DOPA TREATMENT ON CEREBRAL AMINO-ACID LEVELS IN RATS AFTER PORTACAVAL ANASTOMOSIS
    ZANCHIN, G
    RIGOTTI, P
    DUSSINI, N
    BETTINESCHI, F
    VASSANELLI, P
    BATTISTIN, L
    NEUROCHEMICAL RESEARCH, 1981, 6 (06) : 649 - 658
  • [43] L-DOPA: From a biologically inactive amino acid to a successful therapeutic agent Historical review article
    O. Hornykiewicz
    Amino Acids, 2002, 23 : 65 - 70
  • [44] L-DOPA AS SUBSTRATE FOR HUMAN DUODENAL CATECHOL-O-METHYLTRANSFERASE AND AROMATIC L-AMINO-ACID DECARBOXYLASE
    SCHULTZ, E
    BIOMEDICAL CHROMATOGRAPHY, 1990, 4 (06) : 242 - 244
  • [45] L-DOPA treatment modulates the expression and activity of L-aromatic amino acid decarboxylase in the MPTP mouse model
    King, Jennifer
    Mackey, Veronica R.
    Gladson, Muthian
    Charlton, Clivel G.
    FASEB JOURNAL, 2009, 23
  • [46] Large Amino Acid Transporter 1 Selective Liposomes of L-DOPA Functionalized Amphiphile for Combating Glioblastoma
    Bhunia, Sukanya
    Vangala, Venugopal
    Bhattacharya, Dwaipayan
    Ravuri, Halley Gora
    Kuncha, Madhusudana
    Chakravarty, Sumana
    Sistla, Ramakrishna
    Chaudhuri, Arabinda
    MOLECULAR PHARMACEUTICS, 2017, 14 (11) : 3834 - 3847
  • [47] Enhancing Aromatic L-amino Acid Decarboxylase Activity: Implications for L-DOPA Treatment in Parkinson's Disease
    Hadjiconstantinou, Maria
    Neff, Norton H.
    CNS NEUROSCIENCE & THERAPEUTICS, 2008, 14 (04) : 340 - 351
  • [48] L-amino acid transporters and the apical inward and outward transfer of L-DOPA in human and rat intestinal cells
    Fraga, S
    Soares-Da-Silva, P
    FASEB JOURNAL, 2002, 16 (04): : A469 - A469
  • [49] Polymorphisms of the Aromatic L-Amino Acid Decarboxylase Gene Affect the Motor Response to L-Dopa in Parkinson's Disease
    Devos, David
    Lejeune, Stephanie
    Cormier-Dequaire, Florence
    Charbonnier-Beaupel, Fanny
    Rouaix, Nathalie
    Tahiri, Khadija
    Vidailhet, Marie
    Corvol, Jean-Chirstophe
    ANNALS OF NEUROLOGY, 2013, 74 : S42 - S43
  • [50] The influence of L-dopa on methylation capacity in aromatic L-amino acid decarboxylase deficiency:: Biochemical findings in two patients
    Bräutigam, C
    Wevers, RA
    Hyland, K
    Sharma, RK
    Knust, A
    Hoffmann, GF
    JOURNAL OF INHERITED METABOLIC DISEASE, 2000, 23 (04) : 321 - 324